|
Introduction to the Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria: Intravascular Hemolysis and Failed Hematopoiesis (Slides With Transcript)
Jeudi 31 Juillet 2008 - 10:09 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology Paroxysmal nocturnal hemoglobinuria is a rare disease. This symposium will help clinicians to better understand how to make a diagnosis, comprehend what is happening in patients, and advise treatment. |
|
PNH Diagnosis: A Rapidly Changing World (Slides With Audio)
Jeudi 31 Juillet 2008 - 10:09 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology What are the issues related to the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)? What is the utility of flow cytometric procedures in diagnosing PNH? |
|
Optimizing Patient Outcomes in PNH (Slides With Transcript)
Jeudi 31 Juillet 2008 - 10:09 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology What treatments are available for patients with paroxysmal nocturnal hemoglobinuria (PNH)? Learn from one of the leaders in this field, Professor Hubert Schrezenmeier from Germany. |
|
Early Breast Cancer in Older Women
Jeudi 31 Juillet 2008 - 09:00 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology Test your clinical acumen with these 2 challenging cases of breast cancer in elderly women. Medscape Hematology-Oncology |
|
The Management of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances in Diagnosis and Treatment and New Hope for Patients
Jeudi 31 Juillet 2008 - 09:00 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology Outline issues and complications related to paroxysmal nocturnal hemoglobinuria (PNH), and review current and emerging treatment regimens for patients with PNH. |
|
Long-Term Data Confirm Rituximab Plus Chemo in Follicular Lymphoma
Jeudi 31 Juillet 2008 - 07:36 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology Long-term data confirm the benefits of adding rituximab to chemotherapy in the first-line treatment of follicular lymphoma. Medscape Medical News |
|
Latest FDA Labeling Changes for Erythropoiesis-Stimulating Agents
Jeudi 31 Juillet 2008 - 06:34 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology ESAs are no longer indicated for use in cancer patients for chemotherapy-induced anemia if the intent of chemotherapy is to cure the patient. Medscape Medical News |
|
Improving Communication Skills Enhances Efficiency and Patient-Physician Relationships
Jeudi 31 Juillet 2008 - 06:07 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology Effective communication in oncology can enhance quality of care and enable patients and physicians to use time wisely and efficiently, despite the duration of the visit. Medscape Medical News |
|
Guidelines for the Management of Basal Cell Carcinoma
Mercredi 30 Juillet 2008 - 12:14 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology Review updated guidelines for the management of basal cell carcinoma from the British Association of Dermatologists The British Journal of Dermatology |
|
Treatment Strategies for Chemotherapy-Resistant Advanced Breast Cancer
Mercredi 30 Juillet 2008 - 09:00 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology This interactive patient case simulation explores the various treatment options available in managing patients with chemotherapy-resistant, triple-negative breast cancer. Medscape Rheumatology |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 – 21 – 22 – 23 – 24 – 25 – 26 – 27 – 28 >
Actus fournies par : Medscape Hematology-Oncology Headlines